GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Average Rating of “Moderate Buy” by Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have earned a consensus recommendation of “Moderate Buy” from the twelve brokerages that are covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $91.45.

Several brokerages have issued reports on GEHC. Morgan Stanley lifted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research note on Monday, February 12th. HSBC began coverage on shares of GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 price target on the stock. UBS Group raised shares of GE HealthCare Technologies from a “sell” rating to a “neutral” rating and boosted their price target for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Mizuho boosted their price target on shares of GE HealthCare Technologies from $94.00 to $96.00 and gave the company a “buy” rating in a research report on Wednesday, February 7th. Finally, Argus boosted their price target on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday.

GE HealthCare Technologies Price Performance

GE HealthCare Technologies stock opened at $88.11 on Wednesday. The company’s fifty day moving average price is $85.97 and its 200 day moving average price is $76.14. GE HealthCare Technologies has a 1 year low of $62.35 and a 1 year high of $94.50. The stock has a market capitalization of $40.12 billion, a P/E ratio of 29.18, a P/E/G ratio of 3.16 and a beta of 0.95. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The company had revenue of $5.20 billion for the quarter, compared to analysts’ expectations of $5.09 billion. During the same quarter in the previous year, the company posted $1.31 EPS. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. As a group, equities research analysts anticipate that GE HealthCare Technologies will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.14%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.97%.

Institutional Trading of GE HealthCare Technologies

Several institutional investors and hedge funds have recently bought and sold shares of GEHC. Barclays PLC purchased a new stake in GE HealthCare Technologies during the second quarter worth about $92,462,000. Kestra Advisory Services LLC purchased a new stake in GE HealthCare Technologies during the second quarter worth about $905,000. Baird Financial Group Inc. purchased a new stake in GE HealthCare Technologies during the second quarter worth about $4,524,000. Glenview Trust Co purchased a new stake in GE HealthCare Technologies during the second quarter worth about $224,000. Finally, Cerity Partners LLC purchased a new stake in GE HealthCare Technologies during the second quarter worth about $4,789,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.